Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Anti-VEGF Therapy for Retinal Vein Occlusion
Recruiting3 awardsPhase 4
Winston-Salem, North Carolina
This trial will test whether anti-vascular endothelial growth factor therapy can improve vision in patients with retinal vein occlusion and whether measuring the level of vascular endothelial growth factor can help predict when treatment will be needed.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.